|
ABHD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.157000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.920200E-01 |
| Normal-vs-Stage2 |
7.932600E-01 |
| Normal-vs-Stage3 |
7.424600E-01 |
| Normal-vs-Stage4 |
3.675600E-03 |
| Stage1-vs-Stage2 |
5.029200E-01 |
| Stage1-vs-Stage3 |
3.851600E-01 |
| Stage1-vs-Stage4 |
1.875970E-03 |
| Stage2-vs-Stage3 |
9.197000E-01 |
| Stage2-vs-Stage4 |
5.000200E-02 |
| Stage3-vs-Stage4 |
6.684000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.920000E-01 |
| Normal-vs-AfricanAmerican |
1.921370E-01 |
| Normal-vs-Asian |
7.065800E-01 |
| Caucasian-vs-AfricanAmerican |
2.551200E-01 |
| Caucasian-vs-Asian |
9.025400E-01 |
| AfricanAmerican-vs-Asian |
7.928400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.798200E-01 |
| Normal-vs-Female |
1.437590E-02 |
| Male-vs-Female |
8.302000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.656000E-01 |
| Normal-vs-Extreme_Weight |
8.550600E-01 |
| Normal-vs-Obese |
4.022200E-01 |
| Normal-vs-Extreme_Obese |
7.727200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.067400E-01 |
| Normal_Weight-vs-Obese |
1.449240E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.311600E-01 |
| Extreme_Weight-vs-Obese |
3.439400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.081800E-01 |
| Obese-vs-Extreme_Obese |
9.095000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.392400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.366600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.329400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.104000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.722410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.200830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.079360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.323400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.929600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.778600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.299500E-02 |
| Normal-VS-Type2 PRCC |
7.274300E-02 |
| Normal-VS-KIRP CIMP |
1.159830E-01 |
| Normal-VS-Unclassified PRCC |
4.943400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.173700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.984010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.027800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.292240E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.654000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.718430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.278600E-01 |
| Normal-vs-N1 |
3.200600E-01 |
| Normal-vs-N2 |
7.583200E-03 |
| N0-vs-N1 |
7.550600E-01 |
| N0-vs-N2 |
2.761600E-01 |
| N1-vs-N2 |
2.275400E-01 |
|
|
